From single splicing events to thousands: The ambiguous step forward in splicing research

Briefings in Functional Genomics

Volumn 12, Issue 1, 2013, Pages 3-12

  Buratti, Emanuele ^a   Baralle, Marco ^a   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

CLIP; Minigene; RNA splicing; RNAseq; RT PCR; Splicing arrays

Indexed keywords

FIBRONECTIN; RNA;

ALLELE; ARTICLE; BIOINFORMATICS; IN VIVO STUDY; METHODOLOGY; MICROARRAY ANALYSIS; PROTEIN RNA BINDING; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; RESEARCH; RNA SPLICING;

EID: 84872784714     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/els048     Document Type: Article

References (55)

1. Berget SM, Moore C, Sharp PA. Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 1977;74:3171-5.
2. Chow LT, Gelinas RE, Broker TR, et al. An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 1977;12:1-8.
3. Blencowe BJ. Alternative splicing: new insights from global analyses. Cell 2006;126:37-47.
4. Stamm S, Ben-Ari S, Rafalska I, etal. Function of alternative splicing. Gene 2005;344:1-20.
5. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010;463:457-63.
6. Keren H, Lev-Maor G, Ast G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 2010;11:345-55.
7. Skoko N, Baralle M, Tisminetzky S, et al. InTRONs in biotech. Mol Biotechnol 2011;48:290-7.
8. Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta 2009;1792:14-26.
9. Baralle D, Lucassen A, Buratti E. Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBORep 2009;10:810-6.
10. Guthrie C. From the ribosome to the spliceosome and back again. J Biol Chem 2010;285:1-12.
11. Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009;136: 701-18.
12. Semlow DR, Staley JP. Staying on message: ensuring fidelity in pre-mRNA splicing. Trends Biochem Sci 2012;37:263-73.
13. Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 2006;34:3494-510.
14. Isken O, Maquat LE. Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 2007;21:1833-56.
15. Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004;5:89-99.
16. Hicks MJ, Lam BJ, Hertel KJ. Analyzing mechanisms of alternative pre-mRNA splicing using in vitro splicing assays. Methods 2005;37:306-13.
17. Buratti E, Baralle FE. Another step forward for SELEXive splicing. Trends Mol Med 2005;11:5-9.
18. Vibe-Pedersen K, Kornblihtt AR, Baralle FE. Expression of a human alpha-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. Embo J 1984;3:2511-6.
19. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. JMed Genet 2005;42:737-48.
20. Kishore S, Khanna A, Stamm S. Rapid generation of splicing reporters with pSpliceExpress. Gene 2008;427: 104-10.
21. Agafonov DE, Deckert J, Wolf E, et al. Semiquantitative proteomic analysis of the human spliceosome via a novel two-dimensional gel electrophoresis method. Mol Cell Biol 2011;31:2667-82.
22. Mardon HJ, Sebastio G, Baralle FE. A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res 1987;15:7725-33.
23. Smith CW. Alternative splicing-when two's a crowd. Cell 2005;123:1-3.
24. Zubovic L, Baralle M, Baralle FE. Mutually exclusive splicing regulates the Nav 1.6 sodium channel function through a combinatorial mechanism that involves three distinct splicing regulatory elements and their ligands. Nucleic Acids Res 2012;40:6255-69.
25. Buratti E, Dhir A, Lewandowska MA, et al. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res 2007;35: 4369-83.
26. Cramer P, Caceres JF, Cazalla D, et al. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 1999;4:251-8.
27. Baralle M, Skoko N, Knezevich A, et al. NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett 2006;580: 4449-56.
28. Tournier I, Vezain M, Martins A, et al. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat 2008;29:1412-24.
29. Thery JC, Krieger S, Gaildrat P, et al. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. EurJ HumGenet 2011;19:1052-8.
30. Hallegger M, Llorian M, Smith CW. Alternative splicing: global insights. FEBSJ 2010;277:856-66.
31. Licatalosi DD, Mele A, Fak JJ, et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008;456:464-9.
32. Ule J, Ule A, Spencer J, et al. Nova regulates brain-specific splicing to shape the synapse. Nat Genet 2005;37:844-52.
33. Sanford JR, Coutinho P, Hackett JA, et al. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF. PLoS One 2008;3:e3369.
34. Guil S, Caceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat StructMol Biol 2007;14:591-6.
35. Tollervey JR, Curk T, Rogelj B, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. NatNeurosci 2011;14:452-8.
36. Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011;14:459-68.
37. Grellscheid S, Dalgliesh C, Storbeck M, et al. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2beta in development. PLoS Genet 2011;7:e1002390.
38. Huelga SC, Vu AQ, Arnold JD, et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep 2012;1: 167-78.
39. Witten JT, Ule J. Understanding splicing regulation through RNA splicing maps. Trends Genet 2011;27: 89-97.
40. Zhang C, Darnell RB. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITSCLIP data. Nat Biotechnol 2011;29:607-14.
41. Relogio A, Ben-Dov C, Baum M, et al. Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem 2005; 280:4779-84.
42. Rabin SJ, Kim JM, Baughn M, et al. Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. HumMol Genet 2010;19:313-28.
43. Ip JY, Schmidt D, Pan Q, et al. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res 2011;21:390-401.
44. Wang ET, Cody NA, Jog S, et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 2012;150:710-24.
45. Malone JH, Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol 2011;9:34.
46. Pan Q, Shai O, Lee LJ, et al. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008;40:1413-5.
47. Ellis JD, Barrios-Rodiles M, Colak R, et al. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol Cell 2012;46:884-92.
48. Buljan M, Chalancon G, Eustermann S, et al. Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks. Mol Cell 2012;46: 871-83.
49. Hsu SN, Hertel KJ. Spliceosomes walk the line: splicing errors and their impact on cellular function. RNA Biol 2009;6:526-30.
50. Hartmann L, Theiss S, Niederacher D, et al. Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases? Front Biosci 2008;13:3252-72.
51. Zatkova A, Messiaen L, Vandenbroucke I, et al. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. HumMutat 2004;24:491-501.
52. Pagani F, Buratti E, Stuani C, et al. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol Chem 2003;278:26580-88.
53. Ke S, Shang S, Kalachikov SM, et al. Quantitative evaluation of all hexamers as exonic splicing elements. Genome Res 2011;21:1360-74.
54. Houdayer C, Dehainault C, Mattler C, et al. Evaluation of in silico splice tools for decision-making in molecular diagnosis. HumMutat 2008;29:975-82.
55. Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010;7:420-9.